Señales en vivo de 003850.KS | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 abr 2024 @ 02:30):

Boryung Corporation produces and sells pharmaceutical products in South Korea. The company offers cardiovascular products, anticancer products, gastrointestinal products, and API's...

Stats
Volumen de hoy	142 790
Volumen promedio	382 153
Capitalización de mercado	739.01B
EPS	KRW0 ( 2024-04-28 )
Próxima fecha de ganancias	( KRW0 ) 2024-07-25
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW9.58 (0.09%)

Volumen Correlación

Largo: -0.02 (neutral)

Corto: 0.30 (neutral)

Signal:(82.991) Neutral

Boryung Corporation Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Boryung Corporation Correlación - Moneda/Commodity

0.24
( neutral )

0.12
( neutral )

0.44
( neutral )

0.39
( neutral )

-0.59
( weak negative )

-0.16
( neutral )

Boryung Corporation Finanzas

Annual	2023
Ingresos:	KRW859.63B
Beneficio Bruto:	KRW333.27B (38.77 %)
EPS:	KRW610.38

FY	2023
Ingresos:	KRW859.63B
Beneficio Bruto:	KRW333.27B (38.77 %)
EPS:	KRW610.38

FY	2022
Ingresos:	KRW760.48B
Beneficio Bruto:	KRW307.19B (40.39 %)
EPS:	KRW635.91

FY	2021
Ingresos:	KRW627.28B
Beneficio Bruto:	KRW264.94B (42.24 %)
EPS:	KRW725.84

Financial Reports:

No articles found.

Boryung Corporation

Boryung Corporation produces and sells pharmaceutical products in South Korea. The company offers cardiovascular products, anticancer products, gastrointestinal products, and API's. It also exports its products to approximately 50 countries on 6 continents, including Japan, China, the Southeast Asia, the Middle East, Europe, South America, and Africa. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is based in Seoul, South Korea.